Merck (MRK) Adds $5B to Common Buyback
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $145.27 -1.34%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.3%
Revenue Growth %: 0.0%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.3%
Revenue Growth %: 0.0%
Join SI Premium – FREE
Merck (NYSE: MRK) has approved additional purchases of up to $5 billion in common stock.
The company's total current share repurchase program is now $6.4 billion, with today's announcement and the $1.4 billion share repurchase authorization remaining under the program announced on November 24, 2009.
The company's total current share repurchase program is now $6.4 billion, with today's announcement and the $1.4 billion share repurchase authorization remaining under the program announced on November 24, 2009.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Moderna shares plunge on cancer vaccine data leak
- RBC Capital Reiterates Sector Perform Rating on Merck (MRK)
- Provident Financial Holdings approves 5% stock repurchase plan
Create E-mail Alert Related Categories
Hot Buybacks, Stock BuybacksRelated Entities
Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
